shivering. Other specified general symptoms and signs
Conditions
Interventions
Intervention 1: Granisetron(40?g//kg, increased volume to 2 ml) before induction of anesthesia. Intervention 2: Ondansetron(4mg, increased volume to 2 ml) before induction of anesthesia. Intervention
Prevention
Granisetron(40?g//kg, increased volume to 2 ml) before induction of anesthesia
Pethidine (25 mg, inceased volume to 2 ml) before induction of anesthesia
Sponsors
Ardabil University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: Candidate for surgery (General, Orthopedic and ENT surgeries), general anesthesia, ASA class I-II Exclusion criteria: history of substance abuse, presence of neuromuscular diseases, hypersensitivity to the study drugs, evidence of grade 3 or 4 of heart failure, fever (more than 37/8 ° orally), history of alpha2-receptor antagonist drugs consumption
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative shivering. Timepoint: After surgery in recovery room. Method of measurement: Visual analog scale of chills. | — |
Secondary
| Measure | Time frame |
|---|---|
| Central and peripheral temperature. Timepoint: Before the intervention, during surgery, in the recovery room after surgery. Method of measurement: Tympanic and environmental Thermometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Masood Entezariasl
Ardabil University of Medical Sciences
Outcome results
None listed